Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD)

Journal of Neuroimmunology

Volumn 273, Issue 1-2, 2014, Pages 111-114

  Ceylan, Mehmet Fatih ^a   Uneri, Ozden Sukran ^b   Guney, Esra ^b   Ergin, Merve ^a   Alisik, Murat ^a   Goker, Zeynep ^b   Senses Dinc, Gulser ^b   Karaca Kara, Fatma ^b   Erel, Ozcan ^a  

^a YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^b Ankara Pediatric Disease Hematology and Oncology Training and Research Hospital   (Turkey)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Cellular immunity; Neopterin

Indexed keywords

NEOPTERIN;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD LEVEL; BLOOD SAMPLING; BRAIN DYSFUNCTION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NEOPTERIN BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL;

ADHD; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; CELLULAR IMMUNITY; NEOPTERIN;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; HUMANS; MALE; NEOPTERIN;

EID: 84904109594     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.06.002     Document Type: Article

References (39)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC. Fourth Edition.
2. Barkley R.A. ADHD and the Nature of Self Control 1997, 29-65. The Guilford Press, New York.
3. Berdowska A., Zwirska-Korczala K. Neopterin measurement in clinical diagnosis, journal of clinical pharmacy and therapeutics. J. Clin. Pharm. Ther. 2001, 26(5):319-329.
4. Bhutta A.T., Cleves M.A., Casey P.H., Cradock M.M., Anand K.J. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 2002, 288(6):728-737.
5. Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 366(9481):237-248. (16-22).
6. Bodur S., Ceylan M.F., Iseri E., Sener S., Yucel A.A. Serum neopterin levels in patients with autism. Int. J. Dev. Disabil 2013, (Epub ahead of print). 10.1179/2047387713Y.0000000029.
7. Bradstreet J.J., Smith S., Granpeesheh D., El-Dahr J.M., Rossignol D. Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Med. Hypotheses 2007, 68(5):979-987.
8. Castillo L., Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr. Crit. Care Med. 2009, 10(3):387-392.
9. Celik C., Erdem M., Cayci T., Ozdemir B., Ozgur Akgul E., Kurt Y.G., Yaman H., Isintas M., Ozgen F., Ozsahin A. The association between serum levels of neopterin and number of depressive episodes of major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(2):372-375.
10. Cesur S. Neopterin: a marker used for monitoring infections. Mikrobiyol Bull. 2005, 39(2):251-260.
11. Ceylan M.F., Sener S., Bayraktar A.C., Kavutcu M. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin. Neurosci. 2012, 66(3):220-226.
12. Chaste P., Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin. Neurosci. 2012, 14(3):281-292. (Sep).
13. Coskun B., Saral Y., Gödekmerdan A., Erden I., Coskun N. Activation markers in Behçet's disease. Skinmed 2005, 4(5):282-286. (Sep-Oct).
14. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2(2):104-113.
15. Gau S.S., Chang L.Y., Huang L.M., Fan T.Y., Wu Y.Y., Lin T.Y. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics 2008, 122(2):e452-e458.
16. Gokler B., Unal F., Pehlivanturk B., Kultur E.Ç., Akdemir D., Taner Y. Schedule for affective disorders and schizophrenia for school-age children present and lifetime version - the validity and reliability of adaptation in Turkish. Çocuk ve Gençlik Ruh Sagligi Dergisi 2004, 11:109-116.
17. Grizenko N., Shayan Y.R., Polotskaia A., Ter-Stepanian M., Joober R. Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J. Psychiatry Neurosci. 2008, 33(1):10-16.
18. Gulcan E.M., Tirit I., Anil A., Adal E., Ozbay G. Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity. World J. Gastroenterol. 2008, 14(44):6840-6843.
19. Harpin V.A. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch. Dis. Child. 2005, 90:i2-i7.
20. Hoffmann G., Wirleitner B., Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm. Res. 2003, 52(8):313-321.
21. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36(7):980-988.
22. Langley K., Rice F., van den Bree M.B., Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr. 2005, 57(6):359-371.
23. Leslie D.L., Kozma L., Martin A., Landeros A., Katsovich L., King R.A., Leckman J.F. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47(10):1166-1172.
24. Matz J., Krause D.L., Dehning S., Riedel M., Gruber R., Schwarz M.J., Müller N. Altered monocyte activation markers in Tourette's syndrome: a case-control study. BMC Psychiatry 2012, 12:29.
25. Milberger S., Biederman J., Faraone S.V., Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: Findings from a high-risk sample of siblings. J. Clin. Child Psychol. 1998, 27(3):352-358. (Oct).
26. Pacileo M., Cirillo P., De Rosa S., Ucci G., Petrillo G., Musto D'Amore S., Sasso L., Maietta P., Spagnuolo R., Chiariello M. The role of neopterin in cardiovascular disease. Monaldi Arch. Chest Dis. 2007, 68(2):68-73.
27. Passarelli F., Donfrancesco R., Nativio P., Pascale E., Di Trani M., Patti A.M., Vulcano A., Gozzo P., Villa M.P. Anti-Purkinje cell antibody as a biological marker in attention deficit/hyperactivity disorder: a pilot study. J. Neuroimmunol. 2013, 258(1-2):67-70.
28. Rommelse N.N., Franke B., Geurts H.M., Hartman C.A., Buitelaar J.K. Eur. Child Adolesc. Psychiatry 2010, 19(3):281-295.
29. Rowland A.S., Skipper B.J., Umbach D.M., Rabiner D.L., Campbell R.A., Naftel A.J., Sandler D.P. The prevalence of ADHD in a population-based sample. J. Atten. Disord. 2013, (Epub ahead of print).
30. Schweitzer J.B., Lee D.O., Hanford R.B., Tagamets M.A., Hoffman J.M., Grafton S.T., Kilts C.D. A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology 2003, 28(5):967-973. (May).
31. Sucher R., Schroecksnadel K., Weiss G., Margreiter R., Fuchs D., Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010, 287(1):13-22.
32. Sweeten T.L., Posey D.J., McDougle C.J. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 2003, 160(9):1691-1693. (Sep).
33. Van den Berg S.M., Willemsen G., de Geus E.J., Boomsma D.I. Genetic etiology of stability of attention problems in young adulthood. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B(1):55-60.
34. Waldrep D.A. Two cases of ADHD following GABHS infection: a PANDAS subgroup?. J. Am. Acad. Child Adolesc. Psychiatry 2002, 41(11):1273-1274.
35. Wechsler D. WISC-R, Manual for the Wechsler Intelligence Scale for Children-Revised 1974, Psychological Corporation, New York (US).
36. Widner B., Leblhuber F., Fuchs D. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. J. Neural Transm. 2002, 109(2):181-189.
37. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25(2):181-213. (Feb).
38. Young H.A., Geier D.A., Geier M.R. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the vaccine safety datalink. J. Neurol. Sci. 2008, 271(1-2):110-118. (Aug 15).
39. Yüce M., Zoroglu S.S., Ceylan M.F., Kandemir H., Karabekiroglu K. Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey. Neuropsychiatr. Dis. Treat. 2013, 9:1791-1799.